Monitoring hepatitis B in patients starting specialist care
Part of Digestive system, Infections clinical trials.
This study tracks patients with chronic hepatitis B who are seeing a liver specialist for the first time. It aims to improve understanding and care for people living with this infection.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years old or older
- You have a long-term (chronic) hepatitis B infection, confirmed by a positive HBsAg test
- It's your first visit to a participating liver or infectious disease specialist for hepatitis B
- You can provide written consent to take part
- You have national health insurance or equivalent coverage
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at new blood tests (biomarkers) to better understand chronic hepatitis B and how it affects treatment decisions. It may help doctors find better ways to manage your condition.
This study looks at how patients with chronic hepatitis B are managed when they visit non-liver clinics. It aims to improve care and may also include a survey about quality of life for those starting treatment.
This study looks at people who have long-term hepatitis B and how they receive care in Australia. It may help improve understanding of what’s working in real life for patients like you.
This trial is for people with chronic hepatitis B who have already cleared the virus with interferon treatment. It tests ongoing strategies to help maintain their health and prevent the virus from coming back.
This study builds a group of people to measure small hepatitis B “viral RNA” signals in the blood. The goal is to see if these measurements could help researchers find a functional cure and better understand who may respond over time.
This study looks at the genes of people with chronic hepatitis B (HBV) to find why some people's immune cells (B cells and NK cells) stop working properly. The goal is to discover new ways to treat the disease.
Hear when a new Chronic Hepatitis B Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.